2-(4-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)-4-methoxy benzoic acid

ID: ALA4476613

PubChem CID: 139207788

Max Phase: Preclinical

Molecular Formula: C22H19N5O5

Molecular Weight: 433.42

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(C(=O)O)c(NC(=O)c2ccc(Cc3c[nH]c4nc(N)[nH]c(=O)c34)cc2)c1

Standard InChI:  InChI=1S/C22H19N5O5/c1-32-14-6-7-15(21(30)31)16(9-14)25-19(28)12-4-2-11(3-5-12)8-13-10-24-18-17(13)20(29)27-22(23)26-18/h2-7,9-10H,8H2,1H3,(H,25,28)(H,30,31)(H4,23,24,26,27,29)

Standard InChI Key:  IXAPCYKVLYGBPQ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
   14.8291  -18.9935    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.8291  -19.8107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5344  -20.2152    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5344  -18.5808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2397  -18.9935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2442  -19.8072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0194  -20.0544    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.4941  -19.3935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0122  -18.7379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5344  -17.7636    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.1220  -20.2203    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2604  -17.9593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0588  -17.7850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6055  -18.3928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4032  -18.2190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6521  -17.4397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0972  -16.8341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3015  -17.0110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4503  -17.2644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0012  -17.8679    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.6975  -16.4855    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.4956  -16.3101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0422  -16.9145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8397  -16.7396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0876  -15.9600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5318  -15.3551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7364  -15.5331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1819  -14.9324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4250  -14.1522    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.3847  -15.1121    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.3908  -17.3440    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.1432  -18.1227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  2  0
  3  6  1  0
  5  4  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  4 10  2  0
  2 11  1  0
  9 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 16 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 28 29  1  0
 28 30  2  0
 27 28  1  0
 24 31  1  0
 31 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4476613

    ---

Associated Targets(Human)

TYMS Tclin Thymidylate synthase (1651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Bifunctional dihydrofolate reductase-thymidylate synthase (81 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 433.42Molecular Weight (Monoisotopic): 433.1386AlogP: 2.38#Rotatable Bonds: 6
Polar Surface Area: 163.19Molecular Species: ACIDHBA: 6HBD: 5
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.86CX Basic pKa: 1.97CX LogP: 2.91CX LogD: -0.24
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.31Np Likeness Score: -0.54

References

1. Czyzyk DJ, Valhondo M, Deiana L, Tirado-Rives J, Jorgensen WL, Anderson KS..  (2019)  Structure activity relationship towards design of cryptosporidium specific thymidylate synthase inhibitors.,  183  [PMID:31536894] [10.1016/j.ejmech.2019.111673]

Source